Ovarian Cancer Awareness Month
Ovarian cancer encompasses cancers of the ovaries, fallopian tubes, and the primary peritoneum, which is the tissue that lines the abdominal wall and covers the abdominal organs. Taken together, this group is the fifth leading cause of cancer death in women in the United States.
These cancers often go undetected until they’ve reached advanced stages. They may not cause early signs or symptoms, and it is difficult to screen for the disease, according to the National Cancer Institute.
Ovarian cancer is rare – about 1.3 percent of women will be diagnosed with ovarian cancer at some point in their life, according to data from the NCI’s Surveillance, Epidemiology, and End Results Program. An estimated 21,410 women in the United States will be diagnosed with ovarian cancer and 13,770 are expected to die from the disease in 2021.
But because it often goes untreated until the disease has advanced, the survival rate is low, with a five-year survival rate of 49.1 percent.
There are three types of ovarian cancer in adults. Ovarian epithelial cancer begins in the tissue covering the ovary, lining the fallopian tube, or the peritoneum. Ovarian germ cell tumors start in the egg or germ cells. Ovarian low malignant potential tumors begin in the tissue covering the ovary, and are characterized by abnormal cells that may become cancer, but usually do not.
Risk factors for developing ovarian cancer include family history and the presence of inherited gene mutations. There are tests that can detect mutations in the BRCA1 and BRCA2 genes, which increase the risk of female breast and ovarian cancers and some additional types of cancer. Other risk factors include the use of estrogen-only hormone replacement therapy and the use of fertility drugs.
September is Ovarian Cancer Awareness Month.
Ovarian Cancer-Focused Seminar Series
In September 2021, the AACR presents the AACR Virtual Special Conference on Ovarian Cancer. The AACR is committed to supporting the ovarian cancer workforce and ovarian cancer patients. This year will mark the AACR’s fifth Biennial Special Conference on Ovarian Cancer.